Cargando…

Prevalence of pretreatment HIV drug resistance in key populations: a systematic review and meta‐analysis

INTRODUCTION: WHO’s 2019 report on HIV drug resistance (HIVDR) documents a high prevalence of pretreatment drug resistance (PDR) among populations initiating first‐line antiretroviral therapy (ART) in low‐ and middle‐income countries (LMIC). However, systematic evidence on the prevalence of PDR amon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Macdonald, Virginia, Mbuagbaw, Lawrence, Jordan, Michael R, Mathers, Bradley, Jay, Sharon, Baggaley, Rachel, Verster, Annette, Bertagnolio, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758978/ https://www.ncbi.nlm.nih.gov/pubmed/33369131 http://dx.doi.org/10.1002/jia2.25656

Ejemplares similares

A call for differentiated approaches to delivering HIV services to key populations
por: Macdonald, Virginia, et al.
Publicado: (2017)

Values and preferences of contraceptive methods: a mixed-methods study among sex workers from diverse settings
por: Sibanda, Euphemia, et al.
Publicado: (2021)

Attitudes and Acceptability on HIV Self-testing Among Key Populations: A Literature Review
por: Figueroa, Carmen, et al.
Publicado: (2015)

Counselling behavioural interventions for HIV, STI and viral hepatitis among key populations: a systematic review of effectiveness, values and preferences, and cost studies
por: Kennedy, Caitlin E., et al.
Publicado: (2023)

Web-Based Service Provision of HIV, Viral Hepatitis, and Sexually Transmitted Infection Prevention, Testing, Linkage, and Treatment for Key Populations: Systematic Review and Meta-analysis
por: Yeh, Ping Teresa, et al.
Publicado: (2022)

Beyond the 90-90-90: refocusing HIV prevention as part of the global HIV response
por: Baggaley, Rachel, et al.
Publicado: (2016)

Guidelines are needed for studies of pre-treatment HIV drug resistance: a methodological study
por: Mbuagbaw, Lawrence, et al.
Publicado: (2021)

Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery
por: Shaw, Graham, et al.
Publicado: (2023)

Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor–Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis
por: Bertagnolio, Silvia, et al.
Publicado: (2020)

The World Health Organization's work and recommendations for improving the health of trans and gender diverse people
por: Macdonald, Virginia, et al.
Publicado: (2022)

HIV drug resistance surveillance in low- and middle-income countries: 2004 to 2010
por: Bertagnolio, S, et al.
Publicado: (2012)

Young key populations and HIV: a special emphasis and consideration in the new WHO Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations
por: Baggaley, Rachel, et al.
Publicado: (2015)

Developing Reporting Guidelines for Studies of HIV Drug Resistance Prevalence: Protocol for a Mixed Methods Study
por: Garcia, Cristian, et al.
Publicado: (2022)

Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries
por: Ngo-Giang-Huong, Nicole, et al.
Publicado: (2019)

Need assessment for HIV drug resistance testing and landscape of current and future technologies in low- and middle-income countries
por: Parkin, Neil, et al.
Publicado: (2023)

Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub–Saharan Africa
por: Phillips, Andrew N., et al.
Publicado: (2017)

Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China
por: Wang, Zhenyan, et al.
Publicado: (2019)

Cost-effectiveness of implementing HIV and HIV/syphilis dual testing among key populations in Viet Nam: a modelling analysis
por: Coomes, David, et al.
Publicado: (2022)

Prevalence of HIV-1 pretreatment drug resistance among treatment naïve pregnant women in Bissau, Guinea Bissau
por: Wilhelmson, Sten, et al.
Publicado: (2018)

Immediate treatment for recent hepatitis C infection in people with high-risk behaviors: a systematic review and meta-analysis
por: Manoharan, Lakshmi, et al.
Publicado: (2023)

Pretreatment HIV drug resistance spread within transmission clusters in Mexico City
por: Matías-Florentino, Margarita, et al.
Publicado: (2020)

Prevalence of Pretreatment HIV-1 Drug Resistance in Armenia in 2017–2018 and 2020–2021 following a WHO Survey
por: Kirichenko, Alina, et al.
Publicado: (2022)

To err is human, to correct is public health: a systematic review examining poor quality testing and misdiagnosis of HIV status
por: Johnson, Cheryl C., et al.
Publicado: (2017)

The characteristics of pretreatment HIV-1 drug resistance in western Yunnan, China
por: Chen, Min, et al.
Publicado: (2020)

HIV Pretreatment Drug Resistance Trends in Mexico City, 2017–2020
por: García-Morales, Claudia, et al.
Publicado: (2021)

The prevalence of pre‐treatment and acquired HIV drug resistance in Vietnam: a nationally representative survey, 2017–2018
por: Dat, Vu Quoc, et al.
Publicado: (2022)

Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon
por: Tchouwa, Gaëlle F., et al.
Publicado: (2018)

HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru
por: Trebelcock, William L, et al.
Publicado: (2019)

Real-life implications of prevalence meta-analyses? Doi plots and prediction intervals are the answer – Authors' reply
por: Soucy, Jean-Paul R, et al.
Publicado: (2023)

Comparing the effects of HIV self-testing to standard HIV testing for key populations: a systematic review and meta-analysis
por: Witzel, T. Charles, et al.
Publicado: (2020)

Drivers of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) in nine southern African countries: a modelling study
por: Riou, Julien, et al.
Publicado: (2021)

Examining the effects of HIV self-testing compared to standard HIV testing services: a systematic review and meta-analysis
por: Johnson, Cheryl C, et al.
Publicado: (2017)

Moderate Levels of Pretreatment HIV Drug Resistance — Zimbabwe, April–July 2015
por: Da Silva, Juliana, et al.
Publicado: (2017)

Pretreatment HIV drug resistance in adults initiating antiretroviral therapy in China, 2017
por: Kang, Rui-Hua, et al.
Publicado: (2020)

Correction to: Drivers of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) in nine southern African countries: a modelling study
por: Riou, Julien, et al.
Publicado: (2021)

High Levels of Transmitted HIV Drug Resistance in a Study in Papua New Guinea
por: Lavu, Evelyn, et al.
Publicado: (2017)

Reaching people with undiagnosed HIV infection through assisted partner notification
por: Dalal, Shona, et al.
Publicado: (2017)

A Review of Self-Testing for HIV: Research and Policy Priorities in a New Era of HIV Prevention
por: Napierala Mavedzenge, Sue, et al.
Publicado: (2013)

How to set-up a long-distance mentoring program: a framework and case description of mentorship in HIV clinical trials
por: Mbuagbaw, Lawrence, et al.
Publicado: (2013)

Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study
por: Phillips, Andrew N, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hq608he5s2h3sij6ithvh66m28